Almac Showcases Fully Integrated Suite of e-technologies at Partnerships with CROs and EDC & Beyond

March 31, 2008

March 31, 2008. Yardley, PA. On April 14-16, Almac Clinical Technologies will be showcasing it’s fully integrated suite of e-clinical technologies at the joint conference “Partnerships with CROs” and “EDC & Beyond” (co-located at the Mandalay Bay Resort and Casino in Las Vegas). “The built-in integration between our EDC and IVR/IXRS (web and phone) solution allows sponsors to benefit from workflow and cost efficiencies when working with Almac. Our integrated technologies dramatically reduce redundant data entry, time spent reconciling conflicting data, and helps speed a study to data lock,” explains Jim Murphy, President of Almac Clinical Technologies.

Almac’s ability to provide a full range of integrated clinical technology services leads to unique opportunities to partner with CROs. Almac is looking at the CRO Partnerships meeting as an opportunity to explore relationships with Clinical CROs, given the value such arrangements would provide to clients.

“It is highly beneficial for sponsors to work with a clinical CRO and a reputable technology vendor that work as part of an alliance. It allows both the clinical CRO and the sponsor the flexibility to access best-of-breed technology without taking on the fixed costs associated with developing and maintaining expensive technologies in-house. It’s an arrangement that works out great for the CRO and tech provider, but even more so for the client who receives the best solution for its trial.”

Fritz Haas, Vice President of New Products and Services will be presenting at EDC & Beyond on Tuesday afternoon about the role of EDC technology as well as the value of integration between EDC and other clinical technologies. Haas will also assess the current state of EDC technology and discuss future possibilities for the technology.

“EDC is now at a tipping point in terms of adoption by sponsors for clinical trials. In the past, EDC was looked upon mainly as a solution for late stage trials involving large volumes of data or complex designs. Today, however, sponsors are adopting early stage methodologies such as translational medicine and “learn and confirm” which require data sharing between scientists and clinicians involved in early stage development from discovery through proof-of-concept in Phase II. Having all data in electronic form early for dissemination and analysis across teams is vital to improving R&D productivity.”

Come visit Almac at booth #412 in Las Vegas, where you’ll have the opportunity to demo a range of e-technology solutions and win various prizes!

About Almac

Almac Clinical Technologies is a division of the Almac Group that specializes in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS™) for patient randomization; tracking and clinical supply management; iTrial EDC for electronic case report form data collection; electronic patient reported outcome data collection; and web drug reconciliation.

The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, translational genomic services, API manufacture, formulation development, clinical trial supply and technology (IVRS/EDC), to commercial-scale manufacture. Almac provides services to over 600 companies including all the world leaders in the pharmaceutical and biotech sectors. The company employs over 2,000 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California.


Contact: Meghan Adams

T: (001) 267-685-4284

E:[email protected]



Back to news